Quoted By:
>Publication of CRISPR-Cas
>Since 2007 V. Šikšnys focused on mechanistic studies of CRISPR-Cas, the newly discovered bacterial antiviral systems, and was among the first to demonstrate programmable DNA cleavage by the Cas9 protein.[4][5][6][7] According to V.Šikšnys, his article was not even considered as serious by the editor board of the academic journal and was not sent to the reviewers, therefore the time needed to be recognized as first was lost.[8]
>Martin Schlak reported that Šikšnys submitted his article describing DNA cleavage by Cas9 to Cell Reports on April 18, 2012. After its rejection without peer review, he sent it to PNAS one month later, and it took several months for review and publication. In the meantime, Jennifer Doudna and Emmanuelle Charpentier had published their findings in Science where their findings were reviewed and accepted within two weeks.[9]
>The genome editing technology based on Cas9 was licensed to DuPont.[10][11]
